Why did PA8.F stock fall so sharply after hours?

The after-hours decline to EUR 0.093 likely reflects thin liquidity, a gap from prior close, and investor reaction to company-level risk. With just 400 shares traded and a market cap of EUR 870311, small orders can trigger large percent moves in PA8.F stock.

What are the main valuation metrics for PA8.F stock?

Key metrics: market cap EUR 870311, price-to-sales about 0.03, PE roughly -1.50 (negative earnings), revenue per share TTM EUR 4.66, and gross margin near 94.10%. These point to a small, loss-making specialty drug maker.

What does the Meyka grade mean for PA8.F stock?

Meyka AI rates PA8.F at 62.88 (Grade B, HOLD). The grade combines benchmark, sector, financial growth, key metrics and forecasts. It is informational only and not a recommendation; investors should verify fundamentals and catalyst timing.

What short-term forecast figures should investors watch for PA8.F stock?

Meyka AI's model gives a monthly projection of EUR 0.34 and a quarterly projection of EUR 0.06. These imply a wide range; use the upcoming 2026-04-02 earnings update and cash runway disclosures to re-evaluate PA8.F stock exposure.

DE Stocks

PA8.F stock drops 30.86% after hours on 19 Feb 2026: watch cash runway

ByHuzaifa Zahoor February 19, 2026February 19, 2026

PA8.F stock plunged 30.86% in after-hours trading on 19 Feb 2026 to EUR 0.093 on XETRA (Germany), signaling one of the session’s largest losers. Trading volume remained light at 400 shares and market cap sits at EUR 870311, reflecting a very small-cap structure. Investors should note the one-day gap from the previous close of EUR 0.1345, an unusually sharp move for a Healthcare small cap in the Drug Manufacturers – Specialty & Generic industry.